Ticagrelor and Dyspepsia aggravated - a phase IV clinical study of FDA data

Summary:

Dyspepsia aggravated is reported as a side effect among people who take Ticagrelor (ticagrelor), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Asa, and have Psoriasis.

The phase IV clinical study analyzes which people have Dyspepsia aggravated when taking Ticagrelor. It is created by eHealthMe based on reports of 8,473 people who have side effects when taking Ticagrelor from the FDA, and is updated regularly.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 8,499 Ticagrelor users. Check the latest studies of Ticagrelor.

What is Dyspepsia aggravated?

Dyspepsia aggravated (indigestion) is found to be associated with 1,924 drugs and 514 conditions by eHealthMe. Check the latest studies of Dyspepsia aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

8,473 people reported to have side effects when taking Ticagrelor.
Among them, 51 people (0.6%) have Dyspepsia aggravated.

Could Ticagrelor cause Dyspepsia aggravated?

Among these 51 people:

How long have people been on Ticagrelor when they have Dyspepsia aggravated? *

What is the gender of people who have Dyspepsia aggravated when taking Ticagrelor? *

female: 54 %
male: 46 %

What is the age of people who have Dyspepsia aggravated when taking Ticagrelor? *

What are other drugs people take besides Ticagrelor? *

What are other side effects people have besides Dyspepsia aggravated? *

Heart Attack: 20 people, 39.22%
Dizziness: 19 people, 37.25%
Hypotension (abnormally low blood pressure): 17 people, 33.33%
Chest Pain: 17 people, 33.33%
Dyspnea (difficult or laboured breathing): 14 people, 27.45%
Fever: 14 people, 27.45%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 13 people, 25.49%
Diarrhea: 13 people, 25.49%
Headache (pain in head): 13 people, 25.49%
Haemoglobin Decreased: 12 people, 23.53%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 13 people, 25.49%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 11 people, 21.57%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 7 people, 13.73%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 13.73%
High Blood Cholesterol: 6 people, 11.76%
High Blood Pressure: 5 people, 9.80%
Cardiac Failure: 4 people, 7.84%
Cardiac Failure Chronic: 4 people, 7.84%
Diabetes: 4 people, 7.84%
Neuroendocrine Tumor: 4 people, 7.84%

* Approximation only. Some reports may have incomplete information.

Do you take Ticagrelor and have Dyspepsia aggravated?

- Check whether Dyspepsia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ticagrelor:

Ticagrelor (8,499 reports)

Browse all side effects of Ticagrelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspepsia aggravated:

Dyspepsia aggravated (1,924 drugs)

Browse all the conditions that are associated with Dyspepsia aggravated:

Dyspepsia aggravated (514 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ticagrelor (the active ingredients of Ticagrelor) and Ticagrelor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.